X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (70) 70
transplantation (49) 49
male (41) 41
immunology (40) 40
female (34) 34
surgery (33) 33
index medicus (31) 31
adult (29) 29
middle aged (21) 21
graft rejection - immunology (20) 20
hla antigens - immunology (16) 16
rituximab (15) 15
immunoglobulins, intravenous - therapeutic use (14) 14
physics (14) 14
graft rejection - prevention & control (13) 13
kidney transplantation (13) 13
kidney transplantation - adverse effects (13) 13
time factors (13) 13
animals (12) 12
transplantation, homologous (12) 12
adolescent (11) 11
aged (11) 11
desensitization (11) 11
intravenous immunoglobulin (11) 11
child (10) 10
ivig (10) 10
t-lymphocytes - immunology (10) 10
antibodies (9) 9
antibody-mediated rejection (9) 9
cells, cultured (9) 9
therapy (9) 9
treatment outcome (9) 9
allergy and immunology (8) 8
b-lymphocytes - immunology (8) 8
basic electric elements (8) 8
desensitization, immunologic - methods (8) 8
electric solid state devices not otherwise provided for (8) 8
electricity (8) 8
isoantibodies - blood (8) 8
kidney-transplantation (8) 8
lymphocyte culture test, mixed (8) 8
rejection (8) 8
semiconductor devices (8) 8
testing (8) 8
expression (7) 7
flow cytometry (7) 7
graft rejection (7) 7
histocompatibility (7) 7
hla antibodies (7) 7
immune globulin (7) 7
immunosuppressive agents - therapeutic use (7) 7
infection (7) 7
investigating or analysing materials by determining theirchemical or physical properties (7) 7
measuring (7) 7
nephropathy (7) 7
polymerase chain-reaction (7) 7
rats (7) 7
recipients (7) 7
rheumatoid-arthritis (7) 7
t-cells (7) 7
alemtuzumab (6) 6
bk virus (6) 6
disease (6) 6
graft survival (6) 6
graft survival - drug effects (6) 6
inflammation (6) 6
intravenous immune globulin (6) 6
pediatrics (6) 6
polymerase chain reaction (6) 6
renal-transplantation (6) 6
risk factors (6) 6
activation (5) 5
acute humoral rejection (5) 5
allograft recipients (5) 5
allograft-rejection (5) 5
alloimmunity (5) 5
b-lymphocytes - drug effects (5) 5
beer (5) 5
biochemistry (5) 5
chemistry (5) 5
dendritic cells (5) 5
devices or arrangements, the optical operation of which ismodified by changing the optical properties of the medium of thedevices or arrangements for the control of the intensity,colour, phase, polarisation or direction of light, e.g.switching, gating, modulating or demodulating (5) 5
diagnosis (5) 5
dna (5) 5
drug therapy, combination (5) 5
enzyme-linked immunosorbent assay (5) 5
enzymology (5) 5
frequency-changing (5) 5
graft rejection - drug therapy (5) 5
histocompatibility testing (5) 5
immunoglobulins (5) 5
immunoglobulins, intravenous - administration & dosage (5) 5
immunoglobulins, intravenous - adverse effects (5) 5
immunoglobulins, intravenous - pharmacology (5) 5
immunologic factors - therapeutic use (5) 5
immunosuppression (5) 5
immunosuppressive agents - pharmacology (5) 5
interleukin-2 - genetics (5) 5
kidney transplant (5) 5
kidney transplantation - immunology (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2017, Volume 377, Issue 5, pp. 442 - 453
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 2/2013, Volume 110, Issue 6, pp. 2395 - 2400
Journal Article
Transplantation, ISSN 0041-1337, 10/2019, p. 1
BACKGROUND:Antibody-dependent cell-mediated cytotoxicity (ADCC) is an important pathway responsible for antibody-mediated rejection (AMR). Imlifidase (IdeS)... 
Journal Article
Journal Article
Transplantation, ISSN 0041-1337, 07/2014, Volume 98, Issue 2, p. e9
Journal Article
Transplantation, ISSN 0041-1337, 07/2014, Volume 98, Issue 2, pp. e8 - e9
Journal Article
Transplantation, ISSN 0041-1337, 07/2014, Volume 98, Issue 2, pp. e8 - e9
Journal Article
Transplantation, ISSN 0041-1337, 08/2019, p. 1
BACKGROUND:Chronic antibody-mediated rejection (cABMR) results in the majority of renal allograft losses. Currently, there are no approved therapies. We... 
Journal Article
Transplantation, ISSN 0041-1337, 05/2010, Volume 89, Issue 9, pp. 1095 - 1102
Background. We have shown that high-dose intravenous immune globulin (IVIG; 2 g/kg x 2 doses) + rituximab (1 g x 2 doses) was effective in lowering anti-human... 
Acute antibody-mediated rejection | Daclizumab | Acute cell- mediated rejection | Kidney transplant | Rituximab | IVIG | Alemtuzumab | Antithymocyte globulin | Highly sensitized | RHEUMATOID-ARTHRITIS | SURGERY | IMMUNOGLOBULIN | GAMMA-GLOBULIN | IMMUNOLOGY | TRANSPLANTATION | RESISTANT REJECTION | ACUTE HUMORAL REJECTION | INDUCTION THERAPY | ANTIBODY-MEDIATED REJECTION | AUTOIMMUNE-DISEASES | ALLOGRAFT RECIPIENTS | Acute cell-mediated rejection | STAGE RENAL-DISEASE | Humans | Middle Aged | Ganciclovir - analogs & derivatives | Antibodies, Monoclonal - therapeutic use | Male | Flow Cytometry | Virus Diseases - drug therapy | Autoantibodies - drug effects | Aged, 80 and over | Ganciclovir - therapeutic use | Adult | Female | Drug Therapy, Combination | Kidney Failure, Chronic - immunology | Antibodies, Monoclonal, Murine-Derived | Kidney Failure, Chronic - surgery | Antiviral Agents - therapeutic use | Histocompatibility Testing | Graft Rejection - prevention & control | HLA Antigens - immunology | Graft Survival | Survival Rate | Autoantibodies - immunology | Immunoglobulins, Intravenous - therapeutic use | Adolescent | Kidney Transplantation - mortality | T-Lymphocytes - immunology | Aged | Kidney Transplantation - immunology | Virus Diseases - prevention & control | Desensitization, Immunologic - methods | Immunologic Factors - therapeutic use
Journal Article
Transplantation, ISSN 0041-1337, 02/2015, Volume 99, Issue 2, pp. 299 - 308
BACKGROUNDAntibody-mediated rejection (AMR) is a severe form of rejection, mediated primarily by antibody-dependent complement (C) activation. C1 inhibitor... 
SURGERY | DESENSITIZATION | ALLOGRAFT SURVIVAL | INJURY | RENAL-TRANSPLANTATION | IMMUNOLOGY | TRANSPLANTATION | C1 INHIBITOR | KIDNEY-TRANSPLANT RECIPIENTS | INTRAVENOUS IMMUNOGLOBULIN | COMPLEMENT-BINDING | RITUXIMAB | BENEFITS
Journal Article